🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these accounts directly for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Express Worries

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Reaction and Content Elimination

According to the social media company, the service has removed violative content and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the service safe and investing in enhancing compliance measures.

Online Trading Activities

Research also found groups with up to nine thousand members selling retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, populated with images of slimming results, glowing reviews and detailed guides for preparing or injecting at residence.

After moments of entering one group, a vendor shared WhatsApp details, where most purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Product Information and Costs

Within these groups, messages show black plastic parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how much time a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service said it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Although the research behind retatrutide is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously seen individuals injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to potentially serious medical dangers”.